17:26 , Jul 20, 2018 |  BC Week In Review  |  Financial News

DFJ leads Verge Genmics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ on July 16. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259),...
11:01 , Jul 16, 2018 |  BC Extra  |  Financial News

DFJ leads Verge Genomics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259), ALS Investment Fund,...
11:00 , Jul 16, 2018 |  BioCentury  |  Finance

AI on the Verge

For its $32 million series A round, artificial intelligence-guided neurology company Verge Genomics Inc. sought an investor syndicate that reflected its multidisciplinary mind-set. DFJ led the round. New investors included the corporate venture fund of WuXi...
18:35 , Jun 22, 2018 |  BC Week In Review  |  Financial News

Emulate raises $36M series C to improve Organ-Chips offering

Emulate Inc. (Boston, Mass.) raised on June 19 $36 million in a series C round led by Founders Fund. Fellow new investors ALS Investment Fund, SciFi VC and Glass Wall Syndicate also participated, as did...
11:00 , Jun 19, 2018 |  BC Extra  |  Financial News

Emulate raises $36M series C to improve Organ-Chips offering

Emulate Inc. (Boston, Mass.) raised $36 million in a series C round led by Founders Fund. Fellow new investors ALS Investment Fund, SciFi VC and Glass Wall Syndicate also participated, as did undisclosed existing investors. Emulate...
22:01 , Nov 16, 2017 |  BC Extra  |  Financial News

Protein misfolding play Orphazyme prices IPO

Protein misfolding company Orphazyme A/S (CSE:ORPHA TEMP) was unchanged on Thursday after it debuted on NASDAQ Copenhagen, raising DKK 600 million ($94.1 million) in an IPO through the sale of 7.5 million shares at DKK...
21:46 , Mar 10, 2017 |  BC Extra  |  Financial News

Protein misfolding company Orphazyme adds €14M to series B

Orphazyme ApS (Copenhagen, Denmark) added €14 million ($14.9 million) in the second and final close of its series B round, bringing the round's total to €34 million. New investors LSP and the ALS Investment Fund...
20:56 , Mar 10, 2017 |  BC Week In Review  |  Financial News

Orphazyme completes venture financing

On March 8, metabolic and neurological disease company Orphazyme ApS (Copenhagen, Denmark) raised €14 million ($14.9 million) in an extension of a series B round. New investors LSP and the ALS Investment Fund and existing...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Financial News

Amylyx Pharmaceutical completes venture financing

Amylyx Pharmaceutical Corp., Cambridge, Mass.   Business: Neurology   Date completed: 2016-08-22   Type: Venture financing   Raised: $5 million   Investors: Morningside Venture Investments; ALS Investment Fund; private investors; existing investors   ...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

ALS investment fund neurology news

Three entrepreneurs diagnosed with amyotrophic lateral sclerosis (ALS) launched a for-profit investment fund for ALS translational research. The fund hopes to raise €100 million ($138.7 million) and is specifically aimed at "impact investors" rather than...